Purdue Pharma Nalmefene Injection for Opioid OD Reversal
Purdue Pharma has completed the initial phase of a study investigating the use of nalmefene hydrochloride injection (HCl) in...
Jon Napitupulu
Precision’s Exciting HBV Trial: A Breakthrough for Hepatitis B Patients
Precision BioSciences has submitted Clinical Trial Applications (CTAs) to initiate a Phase 1 study for its in vivo gene...
BioAlberta, AxialBridge Team Up to Empower Alberta Life Sciences Companies
BioAlberta has partnered with AxialBridge to support Alberta biotech and MedTech companies in expanding their clinical trials and R&D...
InBrain’s Groundbreaking Graphene-Based Brain Interface: A Revolutionary Breakthrough
INBRAIN Neuroelectronics has made history by performing the world’s first human procedure using its cortical brain-computer interface (BCI) in...
Viviani’s GLP-1 Implant Cleared for Human Trials in Australia: A Revolutionary Approach to Fighting Obesity and Overweight
Vivani Medical announces the approval of its clinical trial for a miniature GLP-1 implant, designed to offer comparable effectiveness...
TAGRISSO Approved for Unresectable Stage III EGFR-Mutated Lung Cancer
AstraZeneca’s TAGRISSO (osimertinib) has received US approval for treating adults with unresectable, Stage III EGFR-mutated non-small cell lung cancersmall...
New Hope for Hormone-Sensitive Prostate Cancer: Nubeqa® Expansion Application Submitted
Bayer submitted a supplemental application to the FDA for NUBEQA, an oral androgen receptor inhibitor combined with androgen deprivation...
Enterprise Therapeutics’ ETD001 Receives Rare Pediatric Disease Designation for Cystic Fibrosis
Enterprise Therapeutics, a biotechnology company specializing in respiratory disease therapies, has earned the “rare pediatric disease designation” (RPD) for...
Innovating FDA Approval for Novel Schizophrenia Treatment
Bristol Myers Squibb’s COBENFY has received FDA approval for treating adult schizophrenia. As a first-of-its-kind medication, COBENFY adopts a...
Curebound Grants $2 Million to Cancer Research Innovations
Curebound, a philanthropic organization dedicated to cancer research, has awarded eight grants totaling $2 million to innovative oncology-based projects....